Showing results (161-170 of 202) with videos related to
Sort By:
Pageof 21
JCO Oncology Practice|March 19, 2025
Facilitated Versus Patient-Directed Advance Care Planning Among Patients With Advanced Cancer: A Randomized Clinical TrialYael Schenker, Shane C Belin, Tianxiu Wang, et al.JCO Oncology Practice|June 25, 2025
Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast CancerAditya Bardia, Hope S Rugo, Mina S Sedrak, et al.JCO Global Oncology|March 14, 2024
Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in IndiaAju Mathew, Sissmol Davis, Jeffrey Mathew Boby, et al.JNCI Cancer Spectrum|August 11, 2021
MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical PracticeAlexander H G Paterson, Peter C Lucas, Stewart J Anderson, et al.Clinical Breast Cancer|August 30, 2016
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II StudyDenise A Yardley, James Reeves, E Claire Dees, et al.Breast Cancer Research : BCR|June 17, 2024
Association of early menarche with breast tumor molecular features and recurrenceAlexandra R Harris, Tengteng Wang, Yujing J Heng, et al.Breast Cancer Research : BCR|September 14, 2017
Alcohol consumption and breast tumor gene expressionJun Wang, Yujing J Heng, A Heather Eliassen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2026
TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in PALB2 or Somatic Mutations in BRCA1 or BRCA2Nadine M Tung, Mark E Robson, Tianyu Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast CancerParvin F Peddi, Peter A Fasching, Duan Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2018
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102Noah Kornblum, Fengmin Zhao, Judith Manola, et al.Pageof 21